Table 77Calcium and preeclampsia and other pregnancy outcomes: Results of cohort studies

Author Year
Study Name
Location
(Latitude)
[PMID]
Age Range, SexOutcome (n/N; Incidence)Followup DurationTotal Ca Intake, mg/dNo. of CasesNo. in CategoryAdjusted OR95% CIP for TrendStudy Quality
Preeclampsia
Morris 2007181
CPEP reanalysis
US
(various)
[11262466]
30–40 y, WomenPreeclampsia (326/4314; 7.6%)ND579NDND1.00 (ref)NDB
580–845NDND0.900.61, 1.30
846–1131NDND0.950.65, 1.39
1132–1560NDND0.970.65, 1.45
1561NDND0.780.49, 1.24
Oken 2007182
Project Viva
US
(42°N)
[17521921]
Preeclampsia (59/1599; 3.7%)A~13005915991.03B0.84, 1.27NSB
High blood pressure with or without proteinuria
Morris 2007181
CPEP reanalysis US
(various)
[11262466]
30–40 y, WomenHigh blood pressure with or without proteinuria (747/4314; 17.3%)ND579NDND1.00 (ref)NDB
580–845NDND1.090.84, 1.42
846–1131NDND1.100.83, 1.44
1132–1560NDND1.140.85, 1.53
1561NDND1.350.98, 1.86
Oken 2007182
Project Viva
US
(42°N)
[17521921]
Pregnancy-induced hypertension (119/1659)CND~130011916590.990.85, 1.15NSB
A

Excludes 119 women with pregnancy-induced hypertension – comparison versus normotensive women

B

Per 300 mg of Ca intake (from supplement or diet)

C

Excludes 59 women with preeclampsia – comparison versus normotensive women

From: 3, Results

Cover of Vitamin D and Calcium
Vitamin D and Calcium: A Systematic Review of Health Outcomes.
Evidence Reports/Technology Assessments, No. 183.
Chung M, Balk EM, Brendel M, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.